Anticancer activities of fatty acids and their heterocyclic derivatives
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Traditional chemotherapy relies on the premise that rapidly proliferating cancer cells are more likely to be killed by a cytotoxic agent, but in reality, the long-standing problem of chemotherapy is the lack of tumor-specific treatments. Apart from the impact on tumor cells, the drugs' major limitation is their severe adverse side effects on normal cells and tissues. Nutritional and epidemiological studies have indicated that cancer progression is correlated with the consumption of fatty acids, but the exact mechanisms still remain unknown. In the first part of our review, we discussed the beneficial effects of free fatty acids (saturated and unsaturated) on the progress of carcinogenesis in different tumor cell lines. We presented various mechanisms proposed in the literature, which explain the possible impact on the cells metabolism. The second part describes modifications of different fatty acids with existing anticancer drugs and heterocyclic moieties by condensation reactions. Such conjugations increased the tissue selectivity and made chemotherapy potentially more effective and less toxic in in vivo and in vitro studies. This fatty acid modifications, which change the activity of compounds, their uptake selectivity and alter drug delivery methods, may be the key to unlocking true medical potential of fatty acids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wall, R., Ross, R. P., Fitzgerald, G. F., & Stanton, C. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00287.x · Cited by 1,101
Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids
Zheng, C. J., Yoo, J.-S., Lee, T.-G., Cho, H.-Y., Kim, Y.-H., & Kim, W.-G. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.08.028 · Cited by 690
From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654
Why do omega-3 fatty acids lower serum triglycerides?
Harris, W. S., & Bulchandani, D. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000236363.63840.16 · Cited by 398
Marventano, S., Kolacz, P., Castellano, S., Galvano, F., Buscemi, S., Mistretta, A., & Grosso, G. (2015) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2015.1077790 · Cited by 220
Casula, M., Soranna, D., Catapano, A. L., & Corrao, G. (2013) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(13)70005-9 · Cited by 152
Cited by
Tomato (Solanum lycopersicum L.) seed: A review on bioactives and biomedical activities
Kumar, M., Tomar, M., Bhuyan, D. J., Punia, S., Grasso, S., Sá, A. G. A., Carciofi, B. A. M., Arrutia, F., Changan, S., Radha, et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112018 · Cited by 130
Kim, D. K., Ediriweera, M. K., Davaatseren, M., Hyun, H. B., & Cho, S. K. (2022) · Food Science & Nutrition · doi:10.1002/fsn3.2702 · Cited by 33
“In addition, linoleic acid has been reported to possess a wide range of anticancer effects (Jóźwiak et al., 2020).”
Background
Metadata
- Authors
- Jóźwiak, M., Filipowska, A., Fiorino, F., & Struga, M.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 871
- Pages
- 172937
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W3000672460
- Cited by
- 158
- References
- 6
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anticancer activities of fatty acids and their heterocyclic derivatives. https://app.cochat.ai/papers/10.1016/j.ejphar.2020.172937
- The paper
- Jóźwiak, M., Filipowska, A., Fiorino, F., & Struga, M. (2020). Anticancer activities of fatty acids and their heterocyclic derivatives. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2020.172937
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.